Rock Creek Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-28
Closed -$12.2K 101
2023
Q3
$12.2K Sell
28
-12
-30% -$5.44K ﹤0.01% 166
2023
Q2
$17.8K Hold
40
﹤0.01% 151
2023
Q1
$18.4K Hold
40
﹤0.01% 161
2022
Q4
$20.5K Hold
40
﹤0.01% 140
2022
Q3
$18K Sell
40
-2
-5% -$957 ﹤0.01% 150
2022
Q2
$20K Hold
42
﹤0.01% 141
2022
Q1
$21K Buy
42
+22
+110% +$10.1K ﹤0.01% 148
2021
Q4
$9K Sell
20
-23
-53% -$9.68K ﹤0.01% 201
2021
Q3
$16K Buy
43
+7
+19% +$2.66K ﹤0.01% 163
2021
Q2
$14K Sell
36
-80
-69% -$30.6K ﹤0.01% 173
2021
Q1
$42K Sell
116
-246
-68% -$79.1K 0.01% 166
2020
Q4
$116K Buy
362
+73
+25% +$22.4K 0.05% 146
2020
Q3
$78K Sell
289
-226
-44% -$60.8K 0.04% 170
2020
Q2
$135K Sell
515
-3,447
-87% -$920K 0.07% 155
2020
Q1
$900K Sell
3,962
-79
-2% -$21.5K 0.5% 58
2019
Q4
$1.23M Buy
4,041
+485
+14% +$133K 0.49% 50
2019
Q3
$854K Buy
3,556
+938
+36% +$257K 0.41% 62
2019
Q2
$739K Sell
2,618
-454
-15% -$124K 0.34% 67
2019
Q1
$882K Sell
3,072
-541
-15% -$156K 0.39% 51
2018
Q4
$949K Sell
3,613
-2,623
-42% -$721K 0.41% 48
2018
Q3
$1.71M Buy
+6,236
New +$1.62M 0.72% 40

Other funds holding ELV

Rock Creek Group's ELV Position: Q4 2023 in Review

Rock Creek Group sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 28 shares — an estimated $12.2K sold.

Rock Creek Group first reported a position in ELV in Q3 2018 and held it in 21 quarters. The position peaked at $1.71M in Q3 2018. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Rock Creek Group reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Rock Creek Group sold 28 Elevance Health shares in Q4 2023, an estimated $12.2K.
  • Rock Creek Group first reported a position in Elevance Health in Q3 2018 and held it in 21 quarters.
  • Rock Creek Group's Elevance Health position peaked at $1.71M in Q3 2018.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Rock Creek Group's 13F filing for Q4 2023, filed 13 Feb 2024.